Stay updated with breaking news from Cell host microbe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antibodies to common-cold viruses, collectively known as hCoV, may hamper the body s response to SARS-CoV-2, according to new data. Earlier studies have disagreed on whether previously acquired hCoV antibodies protect against SARS-CoV-2 infection. ....
By Nancy Lapid (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corrobo. ....
A type of immune-cell priming called trained immunity is helping researchers to understand the disease mechanisms behind the buildup of fatty deposits in arteries ....
1 Abstract The devastating Ebola outbreak in West Africa in 2013-2016 accelerated the progress of several medical countermeasures (MCMs) against Ebola virus disease (EVD). Several IPs were used during that outbreak, but no conclusion on efficacy could be drawn. Only the Randomized Controlled Trial (RCT) on ZMapp was promising but inconclusive. More recently, during the second largest Ebola outbreak in North Kivu and Ituri provinces, Democratic Republic of the Congo (DRC), four IPs (Remdesivir, Regeneron, ZMapp and MAb114) have been evaluated in a RCT, the Pamoja Tulinde Maisha (PALM) study. Two products (Regeneron and MAb114) demonstrated efficacy as compared to the control arm, ZMapp. Very few side effects have been reported. Results from this scientifically sound study led the FDA to license both products, representing a milestone in EVD therapeutic field. These products can be produced relatively inexpensively and can be stockpiled. The administration of mAbs on EVD patients appears ....
There are two certainties about the Covid-19 vaccines being mass-distributed around the world. The first is that governments and the vast majority of mainstream media are pushing with as much ferocity as they can muster for these experimental drugs to be injected into as many people as possible. The second is that those who are brave enough to face the scorn that comes with asking serious questions about the vaccines are absolutely necessary components of our ongoing fight to spread the truth. NOQ Report received an advanced copy of the manuscript in preprint below. It has been prepared by nearly five dozen highly respected doctors, scientists, and public policy experts from across the globe to be urgently sent to world leaders as well as all who are associated with the production and distribution of the various Covid-19 vaccines in circulation today. ....